Related Experiment Video
Updated: Jun 26, 2026
Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays
Published on: June 14, 2024
Hitting the bull's eye: novel directed cancer therapy through helicase-targeted synthetic lethality
Monika Aggarwal1, Robert M Brosh
1Laboratory of Molecular Gerontology, National Institute on Aging, NIH, NIH Biomedical Research Center, 251 Bayview Drive, Baltimore, Maryland 21224, USA.
Abstract:
Designing strategies for anti-cancer therapy have posed a significant challenge. One approach has been to inhibit specific DNA repair proteins and their respective pathways to enhance chemotherapy and radiation therapy used to treat cancer patients. Synthetic lethality represents an approach that exploits pre-existing DNA repair deficiencies in certain tumors to develop inhibitors of DNA repair pathways that compensate for the tumor-associated repair deficiency. Since helicases play critical roles in the DNA damage response and DNA repair, particularly in actively dividing and replicating cells, it is proposed that the identification and characterization of synthetic lethal relationships of DNA helicases will be of value in developing improved anti-cancer treatment strategies. In this review, we discuss this hypothesis and current evidence for synthetic lethal interactions of eukaryotic DNA helicases in model systems.
Insights
Targeting DNA repair pathways, particularly DNA helicases, offers a promising strategy for cancer therapy. Exploiting synthetic lethality in tumors could lead to novel anti-cancer treatments with enhanced efficacy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Developing effective anti-cancer therapies remains a significant challenge.
- Inhibiting DNA repair pathways can enhance chemotherapy and radiation efficacy.
- Synthetic lethality leverages tumor-specific DNA repair deficiencies.
Purpose of the Study:
- To explore the potential of DNA helicases in synthetic lethality for cancer treatment.
- To review current evidence supporting synthetic lethal interactions involving DNA helicases.
Main Methods:
- Review of existing literature on DNA repair pathways and synthetic lethality.
- Focus on the role of eukaryotic DNA helicases in DNA damage response.
- Analysis of model systems demonstrating synthetic lethal interactions.
Main Results:
- DNA helicases are crucial for DNA damage response and repair in rapidly dividing cells.
- Evidence suggests synthetic lethal interactions involving DNA helicases exist.
- These interactions offer potential therapeutic targets.
Conclusions:
- Identifying and characterizing synthetic lethal relationships of DNA helicases is valuable for anti-cancer drug development.
- This approach may lead to improved and more targeted cancer therapies.
- Further research into DNA helicase synthetic lethality is warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
00:55DNA Helicases